Showing 8031-8040 of 18164 results for "".
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines
https://reachmd.com/programs/lipid-luminations/lipidologys-advances-growing-pains-technologies-drug-trials-guidelines/8050/Dr. Steven Nissen discusses major developments in lipidology today, from ultrasound diagnostics to clinical drug trials to guideline recommendations.Egg Freezing Technologies and Techniques: Practical Considerations for Clinicians
https://reachmd.com/programs/clinicians-roundtable/egg-freezing-technologies-practical-considerations-clinicians/7859/Egg freezing, or oocyte cryopreservation, can be a major relief for women who wish to preserve their fertility, allowing patients to wait for the “right time.” What are the latest advances in technology and protocol for this procedure, and who are the right patients? Host Dr. Patrice Basanta Henry wTORS for Sleep Apnea
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/tors-for-sleep-apnea/6416/Sleep apnea is becoming more prevalent in the population, and there are many treatment options. Host Dr. Lee Freedman talks with Dr. Erica Thaler, director of the division of otorhinolaryngology: head and neck surgery at Penn Medicine. Many patients are not willing to be treated, or not treated adeqThe Heart and the Lungs: Linking COPD and Cardiac Output
https://reachmd.com/programs/heart-matters/the-heart-and-the-lungs-linking-copd-and-cardiac-output/5566/When patients present with shortness of breath, physicians often face a quandary: Is it the heart or is it the lungs? What is the relationship between chronic obstructive pulmonary disease, or COPD, and cardiac function? Are patients with even subclinical emphysema at risk for showing reductions inGenetic Risk Factors of Age-Related Macular Degeneration (AMD)
https://reachmd.com/programs/revealing-retina/genetic-risk-factors-of-age-related-macular-degeneration-amd/3925/Geneticists think of age-related macular degeneration (AMD) as a complex trait in which multiple environmental and epidemiological risks combine to cause the disease. Dr. Albert O. Edwards is a consultant and an opthalmologist at the Mayo Clinic in Minnesota, discusses with host Dr. Levitt the genetA Model to Bring MS Research to Bedside Faster
https://reachmd.com/programs/clinicians-roundtable/a-model-to-bring-ms-research-to-bedside-faster/3601/Speeding up the translation process for MS patients is the mission of Fast Forward, LLC, a venture philanthropy of the National Multiple Sclerosis Society. Our guest today, Dr. Timothy Coetzee executive director of Fast Forward, LLC tells us how they are taking a business venture approach to find cuBiology of Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/biology-of-embryonic-stem-cells/2251/John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School in Chicago. Dr. Kessler is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biologyUnderstanding Who Joined COVID-19 Vaccine Trials and Why
https://reachmd.com/programs/clinicians-roundtable/understanding-who-joined-covid-19-vaccine-trials-and-why/36416/Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
https://reachmd.com/programs/clinicians-roundtable/beyond-disease-control-pros-with-odronextamab-in-rr-follicular-lymphoma/37208/In relapsed or refractory follicular lymphoma, disease control is only part of the equation. In this AudioAbstract, ReachMD's Ryan Quigley explores patient-reported outcomes from the ELM-2 trial, revealing that odronextamab not only delivers high response rates but also helps preserve—and in some caClemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
https://reachmd.com/programs/neurofrontiers/clemastine-fumarate-and-progressive-ms-a-closer-look-at-unexpected-risks-and-mechanisms/32825/